Monday, October 17, 2016 Company Report China Merchants Securities (HK) Co., Ltd. Hong Kong Equity Research Please see penultimate page for additional important disclosures. China Merchants Securities (CMS) is a foreign broker-dealer unregistered in the USA. CMS research is prepared by research analysts who are not registered in the USA. CMS research is distributed in the USA pursuant to Rule 15a-6 of the Securities Exchange Act of 1934 solely by Rosenblatt Securities, an SEC registered and FINRA-member broker-dealer. 1 Sinopec Oilfield Services (1033 HK) Record loss in 3Q16E, but the worst is over ■ We expect improved 4Q16E results given generally higher portion of payment settlements in 4Q and recent moderate recovery in oil price after record losses of RMB4.4bn in 3Q16E ■ Management is incentivized to improve results given the share options’ requirement of 6% CAGR in total profit in 2015-19E. We expect 56% CAGR in total profit before tax in 2015-18E ■ Upgraded to BUY from NEUTRAL with a revised TP of HK$1.9 on improved earnings outlook underpinned by recovery in oil price Profit warning with estimated 3Q16E loss of RMB4.4bn SSC released a profit warning indicating estimated net loss of RMB8.9bn in 9M16 with quarterly net loss enlarging from RMB2.8bn in 2Q16 to a record RMB4.4bn in 3Q16E, according to PRC accounting standards, due to continuing cut in the upstream capex as oil price maintaining at low level. Though the moderate 2-14% HoH decline in workload plan for key business segments in 2H16E, the record losses in 3Q16E came far worse than our expectation (previous 2016E loss projection of RMB5.6bn). Meanwhile we believe the worst is over given higher portion of payment settlements in 4Q and recent moderate recovery in oil price. Management incentivized to seek turnaround in 2017E SSC disclosed its A-share option scheme with the first batch of options of 50.85mn shares with an exercise price of RMB5.64/share. Meanwhile, key conditions for the exercise of share options would include performance indicators, such as CAGR of total profit in 2015-19E no less than 6% which we believe would incentivize management to achieve better results by launching stricter cost control, improving efficiency and exploring overseas market proactively. Better fundamentals but trading below its peers We revised 2016E loss projection to RMB8,668mn after taking into account the worse-than-expected 3Q16E results. Meanwhile, we expect a 2017E turnaround given possible rebound in upstream capex amid recovery in oil price, better cost control and increased earnings contribution from engineering construction upon launch of construction of Xin-Yue-Zhe gas pipeline. On the other hand, consensus is still looking for 2017E net loss of RMB408mn versus our net profit projection of RMB451mn. We lifted our TP from HK$1.4 to HK$1.9 which is based on upward revised 1.4x 2017E P/B to reflect recent re-rating of global land drillers (1.4x sector average). We are the first to turn into bullish on SSC among the street as we believe current valuation does not reflect the recent rerating on land drillers which are more sensitive to the recovery in oil price compared to offshore drillers given relative competitive all-in cost for onshore oil and gas production. Financials RMB mn 2014 2015 2016E 2017E 2018E Revenue 78,993 60,349 43,465 52,127 60,248 Growth (%) -12.0% -23.6% -28.0% 19.9% 15.6% Net profit 2,417 (12) (8,668) 451 1,327 Growth (%) 65.0% n/a n/a n/a 194.4% EPS (RMB) 0.16 (0.00) (0.61) 0.03 0.09 DPS (RMB) 0.00 0.00 0.00 0.00 0.00 P/E (x) 8.4 n/a n/a 41.9 14.2 P/B (x) 0.9 0.8 1.2 1.1 1.1 ROE (%) 9.8% -0.1% -42.7% 2.8% 7.8% Sources: Company data, CMS (HK) estimates Anna YU +852 3189 6395 Hebe ZHOU +852 3189 6117 [email protected][email protected]WHAT’S NEW Rating/TP/estimate upgraded BUY Previous NEUTRAL Price HK$1.57 12-month Target Price (Potential up/downside) HK$1.9 (+21%) Previous HK$1.4 Price Performance Source: Bigdata % 1m 6m 12m 1033 HK 2.6 (12.3) (40.1) HSI 0.2 8.9 3.5 Industry: Oil and Gas Hang Seng Index 23233 HSCEI 9804 Key Data 52-week range (HK$) 1.39-2.72 Market cap (HK$ mn) 3297 Avg. daily volume (mn) 7.64 BVPS (HK$) 1.68 Shareholding Structure Sinopec Group 76.6% CITIC 8.59% No. of shares outstanding (mn) 2100 Free float 14.81% Related Research 1. Sinopec Oilfield Services (1033 HK) –Workload to face further downside pressure in 2H16E (NEUTRAL) 2016/09/02 2. Sinopec Oilfield Services (1033 HK) –Deteriorated 2Q16E results despite recovery in oil prices (NEUTRAL) 2016/07/13 3. Sinopec Oilfield Services (1033 HK) –Weakened 1Q16 results in line (NEUTRAL) 2016/05/03 -50 -40 -30 -20 -10 0 10 Oct/15 Feb/16 May/16 Sep/16 (%) 1033 HSI Index
14
Embed
Company Report - niuniuwang.cn · Company Report China Merchants ... among the street as we believe current valuation does not ... oil price compared to offshore drillers given relative
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Monday, October 17, 2016
Company Report China Merchants Securities (HK) Co., Ltd.
Hong Kong Equity Research
Please see penultimate page for additional important disclosures. China Merchants Securities (CMS) is a foreign broker-dealer unregistered in the USA. CMS research is prepared by research analysts who are not registered in the USA. CMS research is distributed in the USA pursuant to Rule 15a-6 of the Securities Exchange Act of 1934 solely by Rosenblatt Securities, an SEC registered and FINRA-member broker-dealer. 1
Sinopec Oilfield Services (1033 HK) Record loss in 3Q16E, but the worst is over ■ We expect improved 4Q16E results given generally higher portion of payment settlements in 4Q and recent moderate recovery in oil price after record losses of RMB4.4bn in 3Q16E ■ Management is incentivized to improve results given the share options’ requirement of 6% CAGR in total profit in 2015-19E. We expect 56% CAGR in total profit before tax in 2015-18E ■ Upgraded to BUY from NEUTRAL with a revised TP of HK$1.9 on improved earnings outlook underpinned by recovery in oil price Profit warning with estimated 3Q16E loss of RMB4.4bn SSC released a profit warning indicating estimated net loss of RMB8.9bn in 9M16 with quarterly net loss enlarging from RMB2.8bn in 2Q16 to a record RMB4.4bn in 3Q16E, according to PRC accounting standards, due to continuing cut in the upstream capex as oil price maintaining at low level. Though the moderate 2-14% HoH decline in workload plan for key business segments in 2H16E, the record losses in 3Q16E came far worse than our expectation (previous 2016E loss projection of RMB5.6bn). Meanwhile we believe the worst is over given higher portion of payment settlements in 4Q and recent moderate recovery in oil price. Management incentivized to seek turnaround in 2017E SSC disclosed its A-share option scheme with the first batch of options of 50.85mn shares with an exercise price of RMB5.64/share. Meanwhile, key conditions for the exercise of share options would include performance indicators, such as CAGR of total profit in 2015-19E no less than 6% which we believe would incentivize management to achieve better results by launching stricter cost control, improving efficiency and exploring overseas market proactively. Better fundamentals but trading below its peers We revised 2016E loss projection to RMB8,668mn after taking into account the worse-than-expected 3Q16E results. Meanwhile, we expect a 2017E turnaround given possible rebound in upstream capex amid recovery in oil price, better cost control and increased earnings contribution from engineering construction upon launch of construction of Xin-Yue-Zhe gas pipeline. On the other hand, consensus is still looking for 2017E net loss of RMB408mn versus our net profit projection of RMB451mn. We lifted our TP from HK$1.4 to HK$1.9 which is based on upward revised 1.4x 2017E P/B to reflect recent re-rating of global land drillers (1.4x sector average). We are the first to turn into bullish on SSC among the street as we believe current valuation does not reflect the recent rerating on land drillers which are more sensitive to the recovery in oil price compared to offshore drillers given relative competitive all-in cost for onshore oil and gas production.
To access our research reports on the Bloomberg terminal, type CMHK <GO> 3
Key beneficiary of possible rebound in upstream capex
As an in-house services company, SSC’s revenue is highly correlated to Sinopec’s upstream capex. Amid plunge in oil price Sinopec plan to cut upstream capex by a further 12.4% YoY to RMB47.9bn in 2016E after 31.8% YoY slash in 2015. Sinopec is the most aggressive oil and gas producer to initiate the capex cut among three oil majors in China with 2016 planned capex 46% below the peak in 2014 versus 34-37% capex cut in 2014-16E for its industry peers. Meanwhile we believe that Sinopec’s upstream capex is the most sensitive to oil price rebound given low base effect in 2016E.
We expect a moderate 10-15% YoY recovery in upstream capex in 2017E underpinned recovery in oil price which we estimate at US$55/bbl in 2017E, up US$10/bbl from 2016E and above breakeven price of US$40-48/bbl for domestic oil producers. We believe that SSC is the key beneficiary from the possible upstream capex rebound given its 96% market share in drilling segment within Sinopec Group.
Following the upstream capex trend, we expect SSC to register 10-20% YoY rebound in workload for key business segments in 2017E after a massive 30-66% YoY drop in 2016E.
Figure 7: Upstream capex of three oil majors
Source: Companies
Figure 8: SSC’s revenue breakdown by client (2015) Figure 9: SSC’s revenue versus Sinopec’s upstream capex
To access our research reports on the Bloomberg terminal, type CMHK <GO> 5
Xin-Yue-Zhe gas pipeline construction – possible to launch in 2017E
We believe the construction of Xinjiang CTG pipeline (Xin-Yue-Zhe gas pipeline) is the key growth driver for SSC in the long run. This pipeline project is Sinopec’s largest project in terms of capex and its total investment is estimated at RMB130bn. Sinopec already got NDRC approval for the project in October 2015. However due to plunge in oil price, the economic return for CTG projects have diminished which triggered the significant delay in construction of CTG projects and related pipelines.
Meanwhile the new pricing mechanism of gas pipeline transmission tariff issued by NDRC in October 2016 specified that the transmission tariff would be determined based on cost-plus principle with permitted investment return of 8% when capacity utilization no less than 75%. We expect impacts on individual pipeline company would be diversified with higher return projects to face downward adjustments for transmission fee while lower return projects to benefit from the permitted return in the long run. For example, the annualized ROA of Sinopec’s Sichuan-to East China Gas Pipeline came in at 12.1% based on 1H16 results, which has exceeded the permitted return. We believe that the speeding up of construction of new gas pipeline would help lower ROA of pipeline assets within Sinopec Group and reduce the risks to cut transmission tariff.
SSC should be a key beneficiary of the construction project given its expertise in the long-distance pipe construction. It successfully constructed or participated in the construction of a series of domestic and overseas large pipe projects including the Sinopec Sichuan-East China gas transmission pipeline, the CNPC gas transmission from West to East China project pipeline 1 and 2, the China-Myanmar oil and gas pipelines, the Brazil GASENE natural gas pipelines, and the Algeria water pipelines.
We estimate the Xin-Yue-Zhe gas pipeline engineering project could bring additional revenue/net profit of RMB26bn/1.6bn in 2017E-20E, accounting for 22% of total profit during the period. Our key assumptions include: 1) project investment of RMB130bn, of which engineering construction capex of RMB52bn; 2) 50% of tenders won by SSC; and 3) a net margin of 6%.
Figure 13: Sinopec’s CTG pipeline projects
Unit Xin-Yue-Zhe gas pipeline Xin-Lu gas pipeline
NDRC approval Preliminary approval (July2013) n/a
Total length Km 8,372 4,463
Trunk line 1 1
Branch lines 6 2
Capacity bcm/y 30 30
Total investment RMB bn 130 86
Covered provinces Xinjiang, Gansu, Ningxia, Shaanxi, Henan,
Shale gas risk compensation on the way but no details yet
SSC got one-off risk compensation upon the completion of Phase I of the Fuling Shale Gas project in 4Q15, which help the significant turnaround in the quarter results (net profit of RMB2.1bn in 4Q15 versus net loss of RMB2.1bn in 9M15). Though Management refused to disclose the specific number for the risk compensation received due to confidential agreement with Sinopec, we believe that risk compensation is the key factor for the dramatic turnaround.
According to the development schedule a total of 317 wells would be drilled in Fuling shale gas basin in 2015-17E with production capacity lifting from 5bcm/y in 2015 to 10bcm/y in 2017E. We estimate the shale gas capex at RMB9/6bn in 2016E/17E assuming a total of 107/75 wells to be drilled during the period. We believe that risk compensation is likely upon the completion of Phase II of the Fuling Shale Gas project. However due to lack of details regarding to the compensation mechanism, we do not include any shale gas risk compensation in our earnings projection in 2017E. Any additional compensation would mean upwards risks to our earnings projection.
Monday, October 17, 2016
To access our research reports on the Bloomberg terminal, type CMHK <GO> 6
Figure 14: Development plan of Fuling Shale Gas project
Figure 15: Production capacity of Fuling Shale Gas project
Source: Company , CMS (HK) estimates Source: Company, CMS (HK)
Management incentivized to seek turnaround in 2017E-19E
SSC disclosed the details regarding to the A-share option scheme with first batch of options of 50.85mn shares
(0.42% of total issued A-share capital or 0.36% of total issued share capital) to be granted to 495 key employees
with an exercise price of RMB5.64/share, 43% premium to current A-share price. The share options could be
exercised in three batches in 3rd
, 4th and 5
th year after the grant date. Meanwhile the key conditions for exercise of
share options would include performance indicators, such as EBITDA on net assets (EOE) no less than 32%,
CAGR of total profit in 2015-17E/18E/19E no less than 6% and economic value added (EVA) achieving the
appraised objectives with ΔEVA greater than zero. We believe that the share options would incentivize
management to achieve better results by launching stricter cost control, improving efficiency and actively exploring
overseas market. As for operating costs, we believe there is potential downside for SG&A ratio as it is much higher compared to Sinopec (6.8% in 2015 versus 3.4% for Sinopec). Management plans to achieve RMB1.3bn cost saving in 2016E, of which RMB437mn cost saved in 1H16. We expect management to continue to implement stricter cost control in next few years with SG&A ratio down to 7% in 2018E.
Figure 16: Cost reduction plan Figure 17: SG&A expenses and ratio
Category 2016 Annual target
Completed in 1H16
Administrative expense 200 70
Labor cost 500 136
Procurement cost 250 155
Maintenance cost 100 29
Renting and services cost 210 126
Financial expense 40 -80
Total 1,300 437
Source: Company, CMS (HK) Source: Company ; CMS (HK) estimates
0
2
4
6
8
10
12
-
20
40
60
80
100
120
2013 2014 2015 2016E 2017E
RMB bn wells Wells drilled (LHS) Capex (RHS)
0.0
2.0
4.0
6.0
8.0
10.0
2015 2017E
bcm/year Phase I Phase II
0.0%
3.0%
6.0%
9.0%
0.0
1.0
2.0
3.0
4.0
5.0
2013 2014 2015 2016E 2017E 2018E
RMB bn SG&A expenses % of total revenue
Monday, October 17, 2016
To access our research reports on the Bloomberg terminal, type CMHK <GO> 7
Figure 18: Proposed share option scheme
Stage Timing Arrangement Conditions for Exercise of Share Options Exercise Ratio Cap
Grant Date To be determined by the Board upon fulfillment of the grant conditions under the Scheme
1st Exercise Period
Commencing on the first trading day after the expiration of 24 months from the Grant Date and ending on the last trading day of 36 months from the Grant Date
In 2017, EOE shall not be less than 32%, the compound growth rate of total profit for 2017 shall not be less than 6% (based on the Company’s total profit for 2015), and the above two indicators shall not be lower than the 75% level of peer benchmark enterprises, the performance of the indicator for economic value added in 2017 has achieved the appraisal objective issued by China Petrochemical Corporation, with EVA greater than zero.
30%
2nd Exercise Period
Commencing on the first trading day after the expiration of 36 months from the Grant Date and ending on the last trading day of 48 months from the Grant Date
In 2018, EOE shall not be less than 32%, the compound growth rate of net profit for 2018 shall not be less than 6% (based on the Company’s total profit for 2015), and the above two indicators shall not be lower than the 75% level of peer benchmark enterprises, the performance of the indicator for economic value added in 2018 has achieved the appraisal objective issued by China Petrochemical Corporation, with EVA greater than zero.
30%
3rd Exercise Period
Commencing on the first trading day after the expiration of 48 months from the Grant Date and ending on the last trading day of 60 months from the Grant Date
In 2019, EOE shall not be less than 32%, the compound growth rate of total profit for 2019 shall not be less than 6% (based on the Company’s total profit for 2015), and the above two indicators shall not be lower than the 75% level of peer benchmark enterprises, the performance of the indicator for economic value added in 2019 has achieved the appraisal objective issued by China Petrochemical Corporation, with EVA greater than zero.
40%
Source: Company
Figure 19: Allocation of proposed share options
Name/Item Position
Number of share options to be granted
Percentage of number of share options to be
granted
Percentage of total share
capital
Directors and senior management
Sun Qingde Director, General Manager, Deputy Secretary of CPC Committee 210,000 0.41% 0.0014%
Zhou Shiliang Director, Secretary of CPC Committee, Deputy General Manager 210,000 0.41% 0.0014%
Zhang Yongjie Deputy General Manager 190,000 0.37% 0.0013%
Wang Chunjiang Deputy Secretary of CPC Committee, Chairman of Labour Union 190,000 0.37% 0.0013%
Lu Baoping Deputy General Manager 190,000 0.37% 0.0013%
Liu Rushan Deputy General Manager 190,000 0.37% 0.0013%
Wang Hongchen Chief Accountant 180,000 0.35% 0.0013%
Zhang Jinhong Deputy General Manager 180,000 0.35% 0.0013%
Huang Songwei Deputy General Manager 180,000 0.35% 0.0013%
Li Honghai Secretary to the Board 140,000 0.28% 0.0009%
Sub-total 10 1,860,000 3.63% 0.0132%
Key business and management personnel of other core positions
Sub-total 485 48,990,000 96.37% 0.3464%
Total 495 50,850,000 100% 0.3596%
Source: Company
Monday, October 17, 2016
To access our research reports on the Bloomberg terminal, type CMHK <GO> 8
Record 3Q16E loss, but the worst is over
SSC released a profit warning indicating estimated net loss of RMB8.9bn in 9M16 with quarterly net loss enlarging from RMB2.8bn in 2Q16 to a record RMB4.4bn in 3Q16E, according to PRC accounting standards, due to continuing cut in the upstream capex as oil price maintaining at low level. Despite the moderate 2-14% HoH decline in workload plan for key business segments in 2H16E, the record losses in 3Q16E came far worse than our expectation (previous 2016E loss projection of RMB5.6bn). Meanwhile we believe the worst is over given higher portion of payment settlements in 4Q and recent moderate recovery in oil price.
We revised 2016E loss projection to RMB8,668mn in 2016E after taking into account the worse-than-expected 3Q16E results. Meanwhile, we expect a turnaround in 2017E given possible rebound in upstream capex amid recovery in oil price, better cost control and increased earnings contribution from engineering construction upon launch of construction of Xin-Yue-Zhe gas pipeline.
Meanwhile we expect gradually improvement in the balance sheet underpinned by earnings turnaround. We estimate net gearing down to 105% by 2018E from the peak of 118% in 2016E.
Working capital chg (1,001) (1,564) 188 (867) (1,490)
Income tax paid (635) (716) (170) (150) (442)
Others 161 185 0 0 0
CF from IA (2,529) (5,003) (2,950) (3,136) (3,435)
Capital expenditure (2,468) (3,745) (3,000) (3,150) (3,465)
Other investments (61) (1,258) 50 14 30
CF from FA (2,465) 3,199 5,819 (233) (1,898)
Borrowings (2,384) (660) 6,600 630 (1,040)
Issue of shares 0 5,953 0 0 0
Dividends (41) 0 0 0 0
Others (40) (2,093) (781) (863) (858)
Net cash flow (492) 791 (1,452) 654 (918)
Beg. Cash 1,694 1,202 1,993 542 1,196
FX changes 0 0 0 0 0
End. Cash 1,202 1,993 542 1,196 278
Profit & Loss Statement RMB million 2014 2015 2016E 2017E 2018E
Revenues 78,993 60,349 43,465 52,127 60,248
Cost of sales (70,675)
(55,317) (47,836) (47,065) (53,731)
SG&A (4,589) (4,105) (3,695) (3,910) (4,217)
Fin. costs (770) (655) (730) (850) (828)
Impairment loss (98) (171) 0 0 0
Investment income 2 1 0 0 0
Profit of JVs (4) (12) (12) (12) (12)
Op Profit 2,859 89 (8,808) 291 1,460
Other income 551 472 400 400 400
Other expenses (90) (92) (90) (90) (90)
PBT 3,320 470 (8,498) 601 1,770
Income taxes (901) (481) (170) (150) (442)
Profit after tax 2,419 (12) (8,668) 451 1,327
Minority interests (2) 0 0 0 0
Net Profit 2,417 (12) (8,668) 451 1,327
EPS (RMB) 0.16 (0.00) (0.61) 0.03 0.09
Financial Ratios
2014 2015 2016E 2017E 2018E
YoY growth rate
Revenue 12.0% -23.6% -28.0% 19.9% 15.6%
Op profit 60.0% -96.9% n/a n/a 401.4%
Net profit 65.0% n/a n/a n/a 194.4%
Profitability
Gross margin 3.6% 0.1% -20.3% 0.6% 2.4%
NP margin 3.1% 0.0% -19.9% 0.9% 2.2%
ROE 9.8% -0.1% -42.7% 2.8% 7.8%
Liquidity
Debt to Asset 15.5% 15.0% 25.8% 24.1% 22.0%
Net Debt to Equity 67.3% 52.1% 121.6% 122.1% 107.2%
Liquid ratio 71.9% 80.4% 65.9% 71.1% 74.4%
Quick ratio 68.7% 77.1% 63.5% 68.2% 71.6%
Operating efficiency
Asset turnover 0.9 0.7 0.5 0.7 0.7
Inventory turnover 27.3 28.2 28.2 28.2 28.2
AR turnover 2.8 2.2 1.7 2.1 2.0
AP turnover 2.3 1.8 1.8 1.8 1.8
Per share ratios (RMB)
EPS 0.16 (0.00) (0.61) 0.03 0.09
CFPS 0.08 0.14 0.04 0.08 0.02
BVPS 1.46 1.74 1.13 1.16 1.25
DPS 0.00 0.00 0.00 0.00 0.00
Valuation ratios
P/E 8.4 n/a n/a 41.9 14.2
P/B 0.9 0.8 1.2 1.1 1.1
EV/EBITDA 3.7 6.3 (6.4) 6.3 4.9
Sources: Company data, CMS (HK) estimates
Monday, October 17, 2016
To access our research reports on the Bloomberg terminal, type CMHK <GO> 13
Investment Ratings
Industry Rating Definition
OVERWEIGHT Expect sector to outperform the market over the next 12 months
NEUTRAL Expect sector to perform in-line with the market over the next 12 months
UNDERWEIGHT Expect sector to underperform the market over the next 12 months
Company Rating Definition
BUY Expect stock to generate 10%+ return over the next 12 months
NEUTRAL Expect stock to generate +10% to -10% over the next 12 months
SELL Expect stock to generate loss of 10%+ over the next 12 months
Analyst Disclosure
The analysts primarily responsible for the preparation of all or part of the research report contained herein hereby certify that: (i) the views expressed in this research report accurately reflect the
personal views of each such analyst about the subject securities and issuers; and (ii) no part of the analyst’s compensation was, is, or will be directly or indirectly, related to the specific
recommendations or views expressed in this research report.
Regulatory Disclosure
Please refer to the important disclosures on our website http://www.newone.com.hk/cmshk/en/disclosure.html.
Disclaimer
This document is prepared by China Merchants Securities (HK) Co., Limited (“CMS HK”). CMS HK is a licensed corporation to carry on Type 1 (dealing in securities), Type 2 (dealing in futures),
Type 4 (advising on securities), Type 6 (advising on corporate finance) and Type 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571). This
document is for information purpose only. Neither the information nor opinion expressed shall be construed, expressly or impl iedly, as an advice, offer or solicitation of an offer, invitation,
advertisement, inducement, recommendation or representation of any kind or form whatsoever to buy or sell any security, financial instrument or any investment or other specific product. The
securities, instruments or strategies discussed in this document may not be suitable for all investors, and certain investors may not be eligible to participate in some or all of them. Certain
services and products are subject to legal restrictions and cannot be offered worldwide on an unrestricted basis and/or may not be eligible for sale to all investors. CMS HK is not registered as a
broker-dealer in the United States and its products and services are not available to U.S. persons except as permitted under SEC Rule 15a-6.
The information and opinions, and associated estimates and forecasts, contained herein have been obtained from or are based on sources believed to be reliable. CMS HK, its holding or
affiliated companies, or any of its or their directors, officers or employees (“CMS Group”) do not represent or warrant, expressly or impliedly, that it is accurate, correct or complete and it should
not be relied upon. CMS Group will not accept any responsibility or liability whatsoever for any use of or reliance upon this document or any of the content thereof. The contents and information
in this document are only current as of the date of their publication and will be subject to change without prior notice. Past performance is not indicative of future performance. Estimates of
future performance are based on assumptions that may not be realized. The analysis contained herein is based on numerous assumptions. Different assumptions could result in materially
different results. Opinions expressed herein may differ or be contrary to those expressed by other business divisions or other members of CMS Group as a result of using different assumptions
and/or criteria.
This document has been prepared without regard to the individual financial circumstances and investment objectives of the persons who receive it. Use of any information herein shall be at the
sole discretion and risk of the user. Investors are advised to independently evaluate particular investments and strategies, take financial and/or tax advice as to the implications (including tax) of
investing in any of the securities or products mentioned in this document, and make their own investment decisions without relying on this publication.
CMS Group may have a long or short position, make markets, act as principal or agent, or engage in transactions in securities of companies referred to in this document and may also perform
or seek to perform investment banking services or provide advisory or other services for those companies. This document is for the use of intended recipients only and this document may not
be reproduced, distributed or published in whole or in part for any purpose without the prior consent of CMS Group. CMS Group will not be liable for any claims or lawsuits from any third parties
arising from the use or distribution of this document. This document is for distribution only under such circumstances as may be permitted by applicable law. This document is not directed at you
if CMS Group is prohibited or restricted by any legislation or regulation in any jurisdiction from making it available to you. In particular, this document is only made available to certain US
persons to whom CMS Group is permitted to make available according to US securities laws, but cannot otherwise be made available, distributed or transmitted, whether directly or indirectly,
into the US or to any US person. This document also cannot be distributed or transmitted, whether directly or indirectly, into Japan and Canada and not to the general public in the People’s
Republic of China (for the purpose of this document, excluding Hong Kong, Macau and Taiwan).
To access our research reports on the Bloomberg terminal, type CMHK <GO> 14
Important Disclosures for U.S. Persons
This research report was prepared by CMS HK, a company authorized to engage in securities activities in Hong Kong. CMS HK is not a registered broker-dealer in the United States and,
therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of research analys ts. This research report is provided for distribution solely to “major
U.S. institutional investors” in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the information provided in this research report
should do so only through Rosenblatt Securities Inc, 40 Wall Street 59th Floor, New York NY 10005, a registered broker dealer in the United States. Under no circumstances should any
recipient of this research report effect any transaction to buy or sell securities or related financial instruments through CMS HK. Rosenblatt Securities Inc. accepts responsibility for the contents
of this research report, subject to the terms set out below.
The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Indus try Regulatory Authority (“FINRA”) and may not be an
associated person of Rosenblatt Securities Inc. and, therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject company, public appearances
and trading securities held by a research analyst account.
Ownership and Material Conflicts of Interest
Rosenblatt Securities Inc. or its affiliates does not ‘beneficially own,’ as determined in accordance with Section 13(d) of the Exchange Act, 1% or more of any of the equity securities mentioned
in the report. Rosenblatt Securities Inc, its affiliates and/or their respective officers, directors or employees may have interests, or long or short positions, and may at any time make purchases
or sales as a principal or agent of the securities referred to herein. Rosenblatt Securities Inc. is not aware of any material conflict of interest as of the date of this publication.
Compensation and Investment Banking Activities
Rosenblatt Securities Inc. or any affiliate has not managed or co-managed a public offering of securities for the subject company in the past 12 months, nor received compensation for
investment banking services from the subject company in the past 12 months, neither does it or any affiliate expect to receive, or intends to seek compensation for investment banking services
from the subject company in the next 3 months.
Additional Disclosures
This research report is for distribution only under such circumstances as may be permitted by applicable law. This research report has no regard to the specific investment objectives, financial
situation or particular needs of any specific recipient, even if sent only to a single recipient. This research report is not guaranteed to be a complete statement or summary of any securities,
markets, reports or developments referred to in this research report. Neither CMS HK nor any of its directors, officers, employees or agents shall have any liability, however arising, for any
error, inaccuracy or incompleteness of fact or opinion in this research report or lack of care in this research report’s preparation or publication, or any losses or damages which may arise from
the use of this research report.
CMS HK may rely on information barriers, such as “Chinese Walls” to control the flow of information within the areas, units, divisions, groups, or affiliates of CMS HK.
Investing in any non-U.S. securities or related financial instruments (including ADRs) discussed in this research report may present certain risks. The securities of non-U.S. issuers may not be
registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on such non-U.S. securities or related financial instruments may be limited.
Foreign companies may not be subject to audit and reporting standards and regulatory requirements comparable to those in effect within the United States.
The value of any investment or income from any securities or related financial instruments discussed in this research report denominated in a currency other than U.S. dollars is subject to
exchange rate fluctuations that may have a positive or adverse effect on the value of or income from such securities or related financial instruments.
Past performance is not necessarily a guide to future performance and no representation or warranty, express or implied, is made by CMS HK with respect to future performance. Income from
investments may fluctuate. The price or value of the investments to which this research report relates, either directly or indirectly, may fall or rise against the interest of investors. Any
recommendation or opinion contained in this research report may become outdated as a consequence of changes in the environment in which the issuer of the securities under analysis
operates, in addition to changes in the estimates and forecasts, assumptions and valuation methodology used herein.
No part of the content of this research report may be copied, forwarded or duplicated in any form or by any means without the prior consent of CMS HK and CMS HK accepts no liability
whatsoever for the actions of third parties in this respect.
Hong Kong
China Merchants Securities (HK) Co., Ltd.
Address: 48/F, One Exchange Square, Central, Hong Kong